大葉大學圖書館 |

言語: 日文

Genetic influences on response to dr...

Rybakowski, Janusz K.

Genetic influences on response to drug treatment for major psychiatric disorders[electronic resource] /

レコード種別:	言語・文字資料 (印刷物) : 単行資料
[NT 15000414] null:	616.89
タイトル / 著者:	Genetic influences on response to drug treatment for major psychiatric disorders/ edited by Janusz K. Rybakowski, Alessandro Serretti.
その他の著者:	Rybakowski, Janusz K.
出版された:	Cham : : Springer International Publishing :, 2016.
記述:	ix, 117 p. : : ill., digital ;; 24 cm.
含まれています:	Springer eBooks
主題:	Psychiatry - Alternative treatment.
主題:	Nature and nurture.
主題:	Genetics.
主題:	Antipsychotic drugs.
主題:	Medicine & Public Health.
主題:	Psychopharmacology.
主題:	Human Genetics.
国際標準図書番号 (ISBN) :	9783319270401
国際標準図書番号 (ISBN) :	9783319270388
[NT 15000228] null:	1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.
[NT 15000229] null:	Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.
電子資源:	http://dx.doi.org/10.1007/978-3-319-27040-1

Genetic influences on response to drug treatment for major psychiatric disorders[electronic resource] /
Genetic influences on response to drug treatment for major psychiatric disorders[electronic resource] /edited by Janusz K. Rybakowski, Alessandro Serretti. - Cham :Springer International Publishing :2016. - ix, 117 p. :ill., digital ;24 cm.

1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.

Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.

ISBN: 9783319270401

Standard No.: 10.1007/978-3-319-27040-1doiSubjects--Topical Terms:

656520
Psychiatry
--Alternative treatment.

LC Class. No.: RC435

Dewey Class. No.: 616.89

Genetic influences on response to drug treatment for major psychiatric disorders[electronic resource] /
LDR:02417nam a2200313 a 4500 001 456831
003 DE-He213
005 20160819150241.0
006 m d
007 cr nn 008maaau
008 161227s2016 gw s 0 eng d
020 $a 9783319270401 $q (electronic bk.)
020 $a 9783319270388 $q (paper)
024 7 $a 10.1007/978-3-319-27040-1 $2 doi
035 $a 978-3-319-27040-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC435
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.89 $2 23
090 $a RC435 $b .G328 2016
245 0 0 $a Genetic influences on response to drug treatment for major psychiatric disorders $h [electronic resource] / $c edited by Janusz K. Rybakowski, Alessandro Serretti.
260 $a Cham : $b Springer International Publishing : $b Imprint: Adis, $c 2016.
300 $a ix, 117 p. : $b ill., digital ; $c 24 cm.
505 0 $a 1. Pharmacogenetics of the Efficacy of Antipsychotic Drugs in Schizophrenia -- 2. Pharmacogenetics of Serious Antipsychotic Side-Effects -- 3. Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs -- 4. Genomic Studies of Treatment Resistance in Major Depressive Disorders -- 5. Complementation of Pharmacogenetics with Biomarkers and Neuroimaging in Major Depression -- 6. Pharmacogenetics of Mood Stabilizers -- 7. Practical Application of Pharmacogenetics of Antipsychotic, Antidepressant and Mood-Stabilizing Drugs.
520 $a Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice.
650 0 $a Psychiatry $x Alternative treatment. $3 656520
650 0 $a Nature and nurture. $3 436906
650 0 $a Genetics. $3 172221
650 0 $a Antipsychotic drugs. $3 480675
650 1 4 $a Medicine & Public Health. $3 463493
650 2 4 $a Psychopharmacology. $3 372108
650 2 4 $a Human Genetics. $3 464334
700 1 $a Rybakowski, Janusz K. $3 656518
700 1 $a Serretti, Alessandro. $3 656519
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-27040-1
950 $a Medicine (Springer-11650)

～に基づいて 0 論評

マルチメディア (複合媒体資料)

マルチメディアファイル
http://dx.doi.org/10.1007/978-3-319-27040-1

論評

論評を追加あなたの考えを共有してください。

Export

受取館